EZH2 inhibition promotes tumor immunogenicity in lung squamous cell carcinomas

Two important factors that contribute to resistance to immune checkpoint inhibitors (ICIs) are an immune-suppressive microenvironment and limited antigen presentation by tumor cells. In this study, we examine if inhibition of the methyltransferase EZH2 can increase ICI response in lung squamous cell...

Descripción completa

Detalles Bibliográficos
Autores principales: DuCote, Tanner J., Song, Xiulong, Naughton, Kassandra J., Chen, Fan, Plaugher, Daniel R., Childress, Avery R., Edgin, Abigail R., Qu, Xufeng, Liu, Jinze, Liu, Jinpeng, Li, Fei, Wong, Kwok-Kin, Brainson, Christine F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10274685/
https://www.ncbi.nlm.nih.gov/pubmed/37333199
http://dx.doi.org/10.1101/2023.06.06.543919

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10274685/
https://www.ncbi.nlm.nih.gov/pubmed/37333199
http://dx.doi.org/10.1101/2023.06.06.543919

Ejemplares similares